and could be even better when they combine it with folfirinox study.
not sure if it’s just me but this company seems to fly under the radar a bit. Looked at verastem website and they’ve got a good investigator sponsored trial programme, about half their current trials are IST. It’s a great way to seed your assets with clinicians , raise profile, get future investigators on board at very low cost (often drug cost only)
Ann: AACR Conference Presentation, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.19M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 150000 | 6.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 150000 | 1 |
View Market Depth
| Last trade - 16.12pm 19/06/2024 (20 minute delay) ? |
| ATX (ASX) Chart |
Day chart unavailable